The Generic Pharmaceutical Association announced that it has named Terry Bazyluk as Vice President for Communications, effective December 1, 2014.
WASHINGTON, D.C. (DECEMBER 2, 2014) — The Generic Pharmaceutical Association (GPhA) announced that it has named Terry Bazyluk as Vice President for Communications, effective December 1, 2014.
Bazyluk has served in senior communications roles for trade associations, corporate CEOs and presidential cabinet secretaries Madeleine Albright, Colin Powell and Robert Reich. His strengths in policy and politics include a legal background and experience working on two winning presidential campaigns. Bazyluk joins GPhA after almost a decade as head of executive communications at Freddie Mac. During a career of more than 25 years, he has gained broad expertise with a range of science, technology and policy subjects.
“We’re delighted to have Terry join the GPhA team. As a top-tier communications professional, he has demonstrated the exceptional writing, messaging and advocacy skills that will cement GPhA’s position as the leading voice of the generic industry,” said Ralph G. Neas, GPhA President and CEO. “Hiring Terry strengthens our efforts to underscore the immense contribution generic medicines make to the healthcare system and to the patients who depend on them.”
“I’m thrilled to join GPhA,” said Bazyluk. “At a time when containing health care costs is more important than ever, the generic pharmaceutical industry has an unequalled track record of delivering quality medicine at lower costs. I am especially excited to work on behalf of an industry that improves so many lives.”
Bazyluk received his BA in Philosophy from Harvard University and his JD from the Yale Law School. Before entering the communications field, he was a law clerk to two federal judges and worked as an attorney at the U.S. Department of Justice and the Washington law firm of Covington & Burling.
GPhA represents the manufacturers and distributors of finished generic pharmaceuticals, manufacturers and distributors of bulk pharmaceutical chemicals, and suppliers of other goods and services to the generic industry. Generic pharmaceuticals fill 86 percent of the prescriptions dispensed in the U.S. but consume just 27 percent of the total drug spending. Additional information is available at gphaonline.org. Follow us on twitter: @gpha.